Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Healthcare
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:CPH)

Cipher Pharmaceuticals Reports Third Quarter 2024 Results

Canada NewsWire November 7, 2024

Cipher Pharmaceuticals Schedules Q3 2024 Earnings Release and Conference Call

Canada NewsWire November 4, 2024

Cipher Pharmaceuticals Enhances Leadership Team with Appointment of New Chief Business Officer

Canada NewsWire October 8, 2024

Cipher Pharmaceuticals Partner Moberg Pharma AB Provides Update on MOB-015 Phase 3 Study

Canada NewsWire September 13, 2024

Canadian Investment Regulatory Organization Trade Resumption - CPH

Canada NewsWire September 13, 2024

Canadian Investment Regulatory Organization Trading Halt - CPH

Canada NewsWire September 13, 2024

Cipher Pharmaceuticals Reports Second Quarter 2024 Results

Canada NewsWire August 8, 2024

Cipher Pharmaceuticals Schedules Q2 2024 Earnings Release and Conference Call

Canada NewsWire August 1, 2024

Cipher Pharmaceuticals acquires rights to dermatology products

Jocelyn Aspa July 29, 2024
View More News ››

Opinion & Analysis (TSX:CPH)

Morning Market Outlook for Aug. 1, 2024

TheUpTrend August 1, 2024

Embrace low-cap biotech for high gains: Eden Rahim of Next Edge Capital

The Life Sciences Report March 2, 2016

How Cipher Pharmaceuticals Is Developing Products for Dermatological Disorders

Dan Levy November 16, 2015

Stockhouse Research: DirectCash craziness and Cipher generic drug battles

Chris Parry September 19, 2013
View More Opinion ››

Bullboard Posts (TSX:CPH)

RE:RE:Stifel

Tbh, I don't see any stocks I own doing well lately.  The only things that are going up nowadays are,  Tech/AI and Crypto.&...
Daudau11 - 11 days ago

RE:Stifel

I had some time to scan the MD&A today. Let me know if I'm missing anything major, but my key takeaways were: Natroba...
drewmumaw - 11 days ago

Stifel

Cipher Pharmaceuticals Target Lowered by Stifel Nicolaus C$19.00 C$17.00
retiredcf - 12 days ago

interesting change in costs of operations

eom
mjh9413 - November 8, 2024

RE:Raised Target

Can't see any reason why the SP has fallen almost 17% in the past 3 weeks other than profit taking or investor jitters. Hopefully the...
retiredcf - November 5, 2024

Raised Target

Cipher Pharmaceuticals Target Raised by Stifel Nicolaus C$17.00 C$19.00
retiredcf - October 25, 2024
View more Bullboard ››

Lithium Ionic Corp

Lithium Ionic Corp

Lithium Ionic Corp. is a Canadian mining company. The Company is engaged exploring and developing its lithium properties in ...
View More »